Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS)

Journal of Neuroimmunology

Volumn 185, Issue 1-2, 2007, Pages 190-194

  Lehmensiek, V ^a   Sussmuth S D ^a   Brettschneider, J ^a   Tauscher, G ^a   Felk, S ^b   Gillardon, F ^b   Tumani, H ^a  

^a UNIVERSITY OF ULM   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

2 D difference in gel electrophoresis; Cerebrospinal fluid; Guillain Barr syndrome; Proteomics

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA II SPECTRIN; AMYLOIDOSIS PATIENT HL HEART PEPTIDE 127AA; CALDESMON; CATHEPSIN D; HAPTOGLOBIN; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN KAPPA CHAIN; PREALBUMIN; PROTEIN; PROTEIN PRECURSOR; PROTEIN SERINE THREONINE KINASE; PROTEIN SNC73; SERINE THREONINE KINASE 10; SPECTRIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ADULT; AGED; CEREBROSPINAL FLUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33947632445     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.01.022     Document Type: Article

References (23)

1. Allen S., Heath P.R., Kirby J., Wharton S.B., Cookson M.R., Menzies F.M., Banks R.E., and Shaw P.J. Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways. J. Biol. Chem. 278 (2003) 6371-6383
2. Asbury A.K., and Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann. Neurol. 27 (1990) S21-S24 Suppl
3. Chamoun V., Zeman A., Blennow K., Fredman P., Wallin A., Keir G., Giovannoni G., and Thompson E.J. Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in normal CSF. J. Neurol. Sci. 182 (2001) 117-121
4. Chopra B., Abraham R., and Abraham A. CSF beta-1 Globulin - a potential marker in differentiating multiple sclerosis and acute disseminated encephalomyelitis: a preliminary study. Neurol. India 50 (2002) 41-44
5. Czogalla A., and Sikorski A.F. Spectrin and calpain: a 'target' and a 'sniper' in the pathology of neuronal cells. Cell. Mol. Life Sci. 62 (2005) 1913-1924
6. Dabrowska R., Kulikova N., and Gagola M. Nonmuscle caldesmon: its distribution and involvement in various cellular processes. Review article. Protoplasma 224 (2004) 1-13
7. Daude N., Ellie E., Reichardt J.K., and Petry K.G. In vivo and in vitro expression of rat galactose-1-phosphate uridyltransferase (GALT) in the developing central and peripheral nervous system. Brain Res. Dev. Brain Res. 94 (1996) 190-196
8. Gutowski N.J., Pinkham J.M., Akanmu D., Chirico S., and Murphy R.P. Free radicals in inflammatory neurological disease: increased lipid peroxidation and haptoglobin levels in Guillain Barre syndrome. Ir. J. Med. Sci. 167 (1998) 43-46
9. Hammack B.N., Fung K.Y., Hunsucker S.W., Duncan M.W., Burgoon M.P., Owens G.P., and Gilden D.H. Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult. Scler. 10 (2004) 245-260
10. Hughes R.A., and Cornblath D.R. Guillain-Barre syndrome. Lancet 366 (2005) 1653-1666
11. Kleyweg R.P., van der Meche F.G., and Schmitz P.I. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. Muscle Nerve 14 (1991) 1103-1109
12. Lehmensiek, V., Süssmuth, S., Tauscher, G., Brettschneider, J., Felk, S., Gillardon, F., Tumani, H., in press. Cerebrospinal fluid proteome profile in Multiple Sclerosis. Mult Scler.
13. Marchi N., Fazio V., Cucullo L., Kight K., Masaryk T., Barnett G., Vogelbaum M., Kinter M., Rasmussen P., Mayberg M.R., and Janigro D. Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption. J. Neurosci. 23 (2003) 1949-1955
14. Matsumura F., and Yamashiro S. Caldesmon. Curr. Opin. Cell Biol. 5 (1993) 70-76
15. McCombe P.A., Clark P., Frith J.A., Hammond S.R., Stewart G.J., Pollard J.D., and McLeod J.G. Alpha-1 antitrypsin phenotypes in demyelinating disease: an association between demyelinating disease and the allele PiM3. Ann. Neurol. 18 (1985) 514-516
16. Ogawa Y., Schafer D.P., Horresh I., Bar V., Hales K., Yang Y., Susuki K., Peles E., Stankewich M.C., and Rasband M.N. Spectrins and ankyrinB constitute a specialized paranodal cytoskeleton. J. Neurosci. 26 (2006) 5230-5239
17. Pengal R.A., Ganesan L.P., Wei G., Fang H., Ostrowski M.C., and Tridandapani S. Lipopolysaccharide-induced production of interleukin-10 is promoted by the serine/threonine kinase Akt. Mol. Immunol. 43 (2006) 1557-1564
18. Rylander M.N., Feng Y., Zhang Y., Bass J., Jason Stafford R., Volgin A., Hazle J.D., and Diller K.R. Optimizing heat shock protein expression induced by prostate cancer laser therapy through predictive computational models. J. Biomed. Opt. 11 (2006) 041113
19. Sadrzadeh S.M., and Bozorgmehr J. Haptoglobin phenotypes in health and disorders. Am. J. Clin. Pathol. 121 (2004) S97-S104
20. Schwagerl A.L., Mohan P.S., Cataldo A.M., Vonsattel J.P., Kowall N.W., and Nixon R.A. Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. J. Neurochem. 64 (1995) 443-446
21. Tsukuba T., Okamoto K., Yasuda Y., Morikawa W., Nakanishi H., and Yamamoto K. New functional aspects of cathepsin D and cathepsin E. Mol. Cells 10 (2000) 601-611
22. Yonekura K., Yokota S., Tanaka S., Kubota H., Fujii N., Matsumoto H., and Chiba S. Prevalence of anti-heat shock protein antibodies in cerebrospinal fluids of patients with Guillain-Barre syndrome. J. Neuroimmunol. 156 (2004) 204-209
23. Zheng S., Cao J., and Geng L. Structure and expression of colorectal cancer related immunoglobulin novel gene SNC73. Zhonghua Yi Xue Za Zhi 81 (2001) 485-488